APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bio Pharma Buffer

A buffer solution is comprised of a weak conjugate acid-base pair, for example, a weak acid and its conjugate base, or a weak base and its conjugate acid. Small quantities of other acids or bases are neutralized when added to the solution, and as a result, the solution resists changes in pH. Solutions with stable pH are required for the processing of protein-based biologic APIs because of their sensitivity to changes in pH. The stable pH range and capacity (the amount of acid/base that can be added without a change in pH) of a buffer are determined by the conjugate acid-base pair.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

A buffer solution is comprised of a weak conjugate acid-base pair, for example, a weak acid and its conjugate base, or a weak base and its conjugate acid. Small quantities of other acids or bases are neutralized when added to the solution, and as a result, the solution resists changes in pH. Solutions with stable pH are required for the processing of protein-based biologic APIs because of their sensitivity to changes in pH. The stable pH range and capacity (the amount of acid/base that can be added without a change in pH) of a buffer are determined by the conjugate acid-base pair.

Most purification steps for downstream processing of biologics require buffers to equilibrate, condition, wash, elute, or concentrate the product. They are used in product isolation and purification steps to facilitate protein capture and polishing and also in the filtration process for the removal of viruses or depyrogenation. Aqueous solutions are also required for cleaning and disinfecting downstream processing equipment, such as chromatography matrices and membrane filtration systems. The main equipment involved in downstream processing with buffers includes mixers for buffer preparation, as well as equipment for purification, including packed-bed chromatography systems, fluidized beds, ultrafiltration and diafiltration membranes, microfiltration membranes, depth filtration cartridges, and virus-removal systems.

Selected research

Industry Growth & Trends

Global Bio Pharma Buffer Industry Growth and Trends Forecast to 2032

21 December 2025104 pages

Choose your research edition.

Industry ResearchBio Pharma Buffer Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Bio Pharma Buffer Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Bio Pharma Buffer Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bio Pharma Buffer Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Bio Pharma Buffer Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

A buffer solution is comprised of a weak conjugate acid-base pair, for example, a weak acid and its conjugate base, or a weak base and its conjugate acid. Small quantities of other acids or bases are neutralized when added to the solution, and as a result, the solution resists changes in pH. Solutions with stable pH are required for the processing of protein-based biologic APIs because of their sensitivity to changes in pH. The stable pH range and capacity (the amount of acid/base that can be added without a change in pH) of a buffer are determined by the conjugate acid-base pair.

Most purification steps for downstream processing of biologics require buffers to equilibrate, condition, wash, elute, or concentrate the product. They are used in product isolation and purification steps to facilitate protein capture and polishing and also in the filtration process for the removal of viruses or depyrogenation. Aqueous solutions are also required for cleaning and disinfecting downstream processing equipment, such as chromatography matrices and membrane filtration systems. The main equipment involved in downstream processing with buffers includes mixers for buffer preparation, as well as equipment for purification, including packed-bed chromatography systems, fluidized beds, ultrafiltration and diafiltration membranes, microfiltration membranes, depth filtration cartridges, and virus-removal systems.

The key players are Avantor, Alfa Aesar (Thermo Fisher), Merck, Lonza, Bio-Rad, BD, GE, Healthcare, Promega Corporation, Hamilton Company, XZL BIO-TECHNOLOGY, SRL and so on. According to the revenue of these companies, we can know that the Bio Pharma Buffer industry is relative concentrated. Because the top 6 companies have more than 70% market share.

Read the full market overview

Report Scope

This report provides a structured, data-driven view of the global Bio Pharma Buffer market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Bio Pharma Buffer market size, estimates, and forecasts are presented in terms of sales volume (K Liter) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Bio Pharma Buffer market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Bio Pharma Buffer.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Bio Pharma Buffer market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Bio Pharma Buffer Market by Company

Avantor

Alfa Aesar (Thermo Fisher)

Merck

Lonza

Bio-Rad

BD

GE Healthcare

Promega Corporation

Hamilton Company

XZL BIO-TECHNOLOGY

SRL

Bio Pharma Buffer Segment by Type

Phosphates Type

Acetates Type

TRIS Type

Others

Bio Pharma Buffer Segment by Application

Research Institution

Pharmaceutical Industry

Others

Bio Pharma Buffer Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bio Pharma Buffer market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bio Pharma Buffer and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bio Pharma Buffer.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Bio Pharma Buffer manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Bio Pharma Buffer in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Phosphates Type Table 2. Major Company of Acetates Type Table 3. Major Company of TRIS Type Table 4. Major Company of Others Table 5. Global Bio Pharma Buffer Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Bio Pharma Buffer Sales by Type (2021-2026) & (K Liter) Table 7. Global Bio Pharma Buffer Sales Market Share in Volume by Type (2021-2026) Table 8. Global Bio Pharma Buffer Sales by Type (2021-2026) & (US$ Million) Table 9. Global Bio Pharma Buffer Sales Market Share in Value by Type (2021-2026) Table 10. Global Bio Pharma Buffer Price by Type (2021-2026) & (USD/Liter) Table 11. Global Bio Pharma Buffer Sales by Type (2027-2032) & (K Liter) Table 12. Global Bio Pharma Buffer Sales Market Share in Volume by Type (2027-2032) Table 13. Global Bio Pharma Buffer Sales by Type (2027-2032) & (US$ Million) Table 14. Global Bio Pharma Buffer Sales Market Share in Value by Type (2027-2032) Table 15. Global Bio Pharma Buffer Price by Type (2027-2032) & (USD/Liter) Table 16. North America Bio Pharma Buffer Sales by Type (2021-2026) & (K Liter) Table 17. North America Bio Pharma Buffer Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Bio Pharma Buffer Sales by Type (2021-2026) & (K Liter) Table 19. Europe Bio Pharma Buffer Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Bio Pharma Buffer Sales by Type (2021-2026) & (K Liter) Table 21. Asia-Pacific Bio Pharma Buffer Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Bio Pharma Buffer Sales by Type (2021-2026) & (K Liter) Table 23. Latin America Bio Pharma Buffer Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Bio Pharma Buffer Sales by Type (2021-2026) & (K Liter) Table 25. Middle East and Africa Bio Pharma Buffer Sales by Type (2021-2026) & (US$ Million) Table 26. Bio Pharma Buffer Industry Trends Table 27. Bio Pharma Buffer Industry Drivers Table 28. Bio Pharma Buffer Industry Opportunities and Challenges Table 29. Bio Pharma Buffer Industry Restraints Table 30. Global Bio Pharma Buffer Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Bio Pharma Buffer Revenue Market Share by Company (2021-2026) Table 32. Global Bio Pharma Buffer Sales by Company (2021-2026) & (K Liter) Table 33. Global Bio Pharma Buffer Sales Share by Company (2021-2026) Table 34. Global Bio Pharma Buffer Market Price by Company (2021-2026) & (USD/Liter) Table 35. Global Bio Pharma Buffer Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Bio Pharma Buffer Major Company Production Sites and Headquarters Table 37. Global Bio Pharma Buffer Company, Product Type & Application Table 38. Global Bio Pharma Buffer Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Bio Pharma Buffer by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Bio Pharma Buffer Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Bio Pharma Buffer Sales by Region (2021-2026) & (K Liter) Table 43. Global Bio Pharma Buffer Sales Market Share in Volume by Region (2021-2026) Table 44. Global Bio Pharma Buffer Sales by Region (2021-2026) & (US$ Million) Table 45. Global Bio Pharma Buffer Sales Market Share in Value by Region (2021-2026) Table 46. Global Bio Pharma Buffer Sales (K Liter), Value (US$ Million), Price (USD/Liter) and Gross Margin (2021-2026) Table 47. Global Bio Pharma Buffer Sales by Region (2027-2032) & (K Liter) Table 48. Global Bio Pharma Buffer Sales Market Share in Volume by Region (2027-2032) Table 49. Global Bio Pharma Buffer Sales by Region (2027-2032) & (US$ Million) Table 50. Global Bio Pharma Buffer Sales Market Share in Value by Region (2027-2032) Table 51. Global Bio Pharma Buffer Sales (K Liter), Value (US$ Million), Price (USD/Liter) and Gross Margin (2027-2032) Table 52. Global Bio Pharma Buffer Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Bio Pharma Buffer Sales by Application (2021-2026) & (K Liter) Table 54. Global Bio Pharma Buffer Sales Market Share in Volume by Application (2021-2026) Table 55. Global Bio Pharma Buffer Sales by Application (2021-2026) & (US$ Million) Table 56. Global Bio Pharma Buffer Sales Market Share in Value by Application (2021-2026) Table 57. Global Bio Pharma Buffer Price by Application (2021-2026) & (USD/Liter) Table 58. Global Bio Pharma Buffer Sales by Application (2027-2032) & (K Liter) Table 59. Global Bio Pharma Buffer Sales Market Share in Volume by Application (2027-2032) Table 60. Global Bio Pharma Buffer Sales by Application (2027-2032) & (US$ Million) Table 61. Global Bio Pharma Buffer Sales Market Share in Value by Application (2027-2032) Table 62. Global Bio Pharma Buffer Price by Application (2027-2032) & (USD/Liter) Table 63. North America Bio Pharma Buffer Sales by Application (2021-2026) & (K Liter) Table 64. North America Bio Pharma Buffer Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Bio Pharma Buffer Sales by Application (2021-2026) & (K Liter) Table 66. Europe Bio Pharma Buffer Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Bio Pharma Buffer Sales by Application (2021-2026) & (K Liter) Table 68. Asia-Pacific Bio Pharma Buffer Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Bio Pharma Buffer Sales by Application (2021-2026) & (K Liter) Table 70. Latin America Bio Pharma Buffer Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Bio Pharma Buffer Sales by Application (2021-2026) & (K Liter) Table 72. Middle East and Africa Bio Pharma Buffer Sales by Application (2021-2026) & (US$ Million) Table 73. Avantor Company Information Table 74. Avantor Business Overview Table 75. Avantor Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2021-2026) Table 76. Avantor Bio Pharma Buffer Product Portfolio Table 77. Avantor Recent Development Table 78. Alfa Aesar (Thermo Fisher) Company Information Table 79. Alfa Aesar (Thermo Fisher) Business Overview Table 80. Alfa Aesar (Thermo Fisher) Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2021-2026) Table 81. Alfa Aesar (Thermo Fisher) Bio Pharma Buffer Product Portfolio Table 82. Alfa Aesar (Thermo Fisher) Recent Development Table 83. Merck Company Information Table 84. Merck Business Overview Table 85. Merck Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2021-2026) Table 86. Merck Bio Pharma Buffer Product Portfolio Table 87. Merck Recent Development Table 88. Lonza Company Information Table 89. Lonza Business Overview Table 90. Lonza Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2021-2026) Table 91. Lonza Bio Pharma Buffer Product Portfolio Table 92. Lonza Recent Development Table 93. Bio-Rad Company Information Table 94. Bio-Rad Business Overview Table 95. Bio-Rad Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2021-2026) Table 96. Bio-Rad Bio Pharma Buffer Product Portfolio Table 97. Bio-Rad Recent Development Table 98. BD Company Information Table 99. BD Business Overview Table 100. BD Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2021-2026) Table 101. BD Bio Pharma Buffer Product Portfolio Table 102. BD Recent Development Table 103. GE Healthcare Company Information Table 104. GE Healthcare Business Overview Table 105. GE Healthcare Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2021-2026) Table 106. GE Healthcare Bio Pharma Buffer Product Portfolio Table 107. GE Healthcare Recent Development Table 108. Promega Corporation Company Information Table 109. Promega Corporation Business Overview Table 110. Promega Corporation Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2021-2026) Table 111. Promega Corporation Bio Pharma Buffer Product Portfolio Table 112. Promega Corporation Recent Development Table 113. Hamilton Company Company Information Table 114. Hamilton Company Business Overview Table 115. Hamilton Company Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2021-2026) Table 116. Hamilton Company Bio Pharma Buffer Product Portfolio Table 117. Hamilton Company Recent Development Table 118. XZL BIO-TECHNOLOGY Company Information Table 119. XZL BIO-TECHNOLOGY Business Overview Table 120. XZL BIO-TECHNOLOGY Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2021-2026) Table 121. XZL BIO-TECHNOLOGY Bio Pharma Buffer Product Portfolio Table 122. XZL BIO-TECHNOLOGY Recent Development Table 123. SRL Company Information Table 124. SRL Business Overview Table 125. SRL Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2021-2026) Table 126. SRL Bio Pharma Buffer Product Portfolio Table 127. SRL Recent Development Table 128. North America Bio Pharma Buffer Market Size Growth Rate (CAGR) by Country (K Liter): 2021 VS 2025 VS 2032 Table 129. North America Bio Pharma Buffer Sales by Country (2021-2026) & (K Liter) Table 130. North America Bio Pharma Buffer Sales Market Share by Country (2021-2026) Table 131. North America Bio Pharma Buffer Sales Forecast by Country (2027-2032) & (K Liter) Table 132. North America Bio Pharma Buffer Sales Market Share Forecast by Country (2027-2032) Table 133. North America Bio Pharma Buffer Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. North America Bio Pharma Buffer Market Size by Country (2021-2026) & (US$ Million) Table 135. North America Bio Pharma Buffer Market Share by Country (2021-2026) Table 136. North America Bio Pharma Buffer Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. North America Bio Pharma Buffer Market Share Forecast by Country (2027-2032) Table 138. Europe Bio Pharma Buffer Market Size Growth Rate (CAGR) by Country (K Liter): 2021 VS 2025 VS 2032 Table 139. Europe Bio Pharma Buffer Sales by Country (2021-2026) & (K Liter) Table 140. Europe Bio Pharma Buffer Sales Market Share by Country (2021-2026) Table 141. Europe Bio Pharma Buffer Sales Forecast by Country (2027-2032) & (K Liter) Table 142. Europe Bio Pharma Buffer Sales Market Share Forecast by Country (2027-2032) Table 143. Europe Bio Pharma Buffer Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Europe Bio Pharma Buffer Market Size by Country (2021-2026) & (US$ Million) Table 145. Europe Bio Pharma Buffer Market Share by Country (2021-2026) Table 146. Europe Bio Pharma Buffer Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Europe Bio Pharma Buffer Market Share Forecast by Country (2027-2032) Table 148. Asia-Pacific Bio Pharma Buffer Market Size Growth Rate (CAGR) by Country (K Liter): 2021 VS 2025 VS 2032 Table 149. Asia-Pacific Bio Pharma Buffer Sales by Country (2021-2026) & (K Liter) Table 150. Asia-Pacific Bio Pharma Buffer Sales Market Share by Country (2021-2026) Table 151. Asia-Pacific Bio Pharma Buffer Sales Forecast by Country (2027-2032) & (K Liter) Table 152. Asia-Pacific Bio Pharma Buffer Sales Market Share Forecast by Country (2027-2032) Table 153. Asia-Pacific Bio Pharma Buffer Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Asia-Pacific Bio Pharma Buffer Market Size by Country (2021-2026) & (US$ Million) Table 155. Asia-Pacific Bio Pharma Buffer Market Share by Country (2021-2026) Table 156. Asia-Pacific Bio Pharma Buffer Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Asia-Pacific Bio Pharma Buffer Market Share Forecast by Country (2027-2032) Table 158. Latin America Bio Pharma Buffer Market Size Growth Rate (CAGR) by Country (K Liter): 2021 VS 2025 VS 2032 Table 159. Latin America Bio Pharma Buffer Sales by Country (2021-2026) & (K Liter) Table 160. Latin America Bio Pharma Buffer Sales Market Share by Country (2021-2026) Table 161. Latin America Bio Pharma Buffer Sales Forecast by Country (2027-2032) & (K Liter) Table 162. Latin America Bio Pharma Buffer Sales Market Share Forecast by Country (2027-2032) Table 163. Latin America Bio Pharma Buffer Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Latin America Bio Pharma Buffer Market Size by Country (2021-2026) & (US$ Million) Table 165. Latin America Bio Pharma Buffer Market Share by Country (2021-2026) Table 166. Latin America Bio Pharma Buffer Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Latin America Bio Pharma Buffer Market Share Forecast by Country (2027-2032) Table 168. Middle East and Africa Bio Pharma Buffer Market Size Growth Rate (CAGR) by Country (K Liter): 2021 VS 2025 VS 2032 Table 169. Middle East and Africa Bio Pharma Buffer Sales by Country (2021-2026) & (K Liter) Table 170. Middle East and Africa Bio Pharma Buffer Sales Market Share by Country (2021-2026) Table 171. Middle East and Africa Bio Pharma Buffer Sales Forecast by Country (2027-2032) & (K Liter) Table 172. Middle East and Africa Bio Pharma Buffer Sales Market Share Forecast by Country (2027-2032) Table 173. Middle East and Africa Bio Pharma Buffer Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Middle East and Africa Bio Pharma Buffer Market Size by Country (2021-2026) & (US$ Million) Table 175. Middle East and Africa Bio Pharma Buffer Market Share by Country (2021-2026) Table 176. Middle East and Africa Bio Pharma Buffer Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Middle East and Africa Bio Pharma Buffer Market Share Forecast by Country (2027-2032) Table 178. Key Raw Materials Table 179. Raw Materials Key Suppliers Table 180. Bio Pharma Buffer Distributors List Table 181. Bio Pharma Buffer Customers List Table 182. Research Programs/Design for This Report Table 183. Authors List of This Report Table 184. Secondary Sources Table 185. Primary Sources List of Figures Figure 1. Bio Pharma Buffer Image Figure 2. Global Bio Pharma Buffer Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bio Pharma Buffer Market Size (2021-2032) & (US$ Million) Figure 4. Global Bio Pharma Buffer Sales (2021-2032) & (K Liter) Figure 5. Phosphates Type Image Figure 6. Global Phosphates Type Sales YoY Growth (2021-2032) & (K Liter) Figure 7. Acetates Type Image Figure 8. Global Acetates Type Sales YoY Growth (2021-2032) & (K Liter) Figure 9. TRIS Type Image Figure 10. Global TRIS Type Sales YoY Growth (2021-2032) & (K Liter) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (K Liter) Figure 13. Global Bio Pharma Buffer Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Bio Pharma Buffer Market Share by Type 2025 VS 2032 Figure 15. North America Bio Pharma Buffer Sales Market Share in Volume by Type in 2025 Figure 16. North America Bio Pharma Buffer Sales Market Share in Value by Type in 2025 Figure 17. Europe Bio Pharma Buffer Sales Market Share in Volume by Type in 2025 Figure 18. Europe Bio Pharma Buffer Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Bio Pharma Buffer Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Bio Pharma Buffer Sales Market Share in Value by Type in 2025 Figure 21. Latin America Bio Pharma Buffer Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Bio Pharma Buffer Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Bio Pharma Buffer Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Bio Pharma Buffer Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Bio Pharma Buffer Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Research Institution Image Figure 28. Global Research Institution Sales YoY Growth (2021-2032) & (K Liter) Figure 29. Pharmaceutical Industry Image Figure 30. Global Pharmaceutical Industry Sales YoY Growth (2021-2032) & (K Liter) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (K Liter) Figure 33. Global Bio Pharma Buffer Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Bio Pharma Buffer Market Share by Application 2025 VS 2032 Figure 35. North America Bio Pharma Buffer Sales Market Share in Volume by Application in 2025 Figure 36. North America Bio Pharma Buffer Sales Market Share in Value by Application in 2025 Figure 37. Europe Bio Pharma Buffer Sales Market Share in Volume by Application in 2025 Figure 38. Europe Bio Pharma Buffer Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Bio Pharma Buffer Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Bio Pharma Buffer Sales Market Share in Value by Application in 2025 Figure 41. Latin America Bio Pharma Buffer Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Bio Pharma Buffer Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Bio Pharma Buffer Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Bio Pharma Buffer Sales Market Share in Value by Application in 2025 Figure 45. North America Bio Pharma Buffer Sales by Country: 2021 VS 2025 VS 2032 (K Liter) Figure 46. North America Bio Pharma Buffer Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Bio Pharma Buffer Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Bio Pharma Buffer Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Bio Pharma Buffer Sales by Country: 2021 VS 2025 VS 2032 (K Liter) Figure 50. Europe Bio Pharma Buffer Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Bio Pharma Buffer Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Bio Pharma Buffer Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Bio Pharma Buffer Sales by Country: 2021 VS 2025 VS 2032 (K Liter) Figure 54. Asia-Pacific Bio Pharma Buffer Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Bio Pharma Buffer Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Bio Pharma Buffer Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Bio Pharma Buffer Sales by Country: 2021 VS 2025 VS 2032 (K Liter) Figure 58. Latin America Bio Pharma Buffer Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Bio Pharma Buffer Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Bio Pharma Buffer Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Bio Pharma Buffer Sales by Country: 2021 VS 2025 VS 2032 (K Liter) Figure 62. Middle East and Africa Bio Pharma Buffer Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Bio Pharma Buffer Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Bio Pharma Buffer Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Bio Pharma Buffer Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Bio Pharma Buffer Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Phosphates Type
  • Acetates Type
  • TRIS Type
  • Others
Applications
  • Research Institution
  • Pharmaceutical Industry
  • Others
Companies covered
  • Avantor
  • Alfa Aesar (Thermo Fisher)
  • Merck
  • Lonza
  • Bio-Rad
  • BD
  • GE Healthcare
  • Promega Corporation
  • Hamilton Company
  • XZL BIO-TECHNOLOGY
  • SRL

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Bio Pharma Buffer Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Bio Pharma Buffer Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Bio Pharma Buffer Market by Type
  6. 1.3.1 Phosphates Type
  7. 1.3.2 Acetates Type
  8. 1.3.3 TRIS Type
  9. 1.3.4 Others
  10. 1.4 Global Bio Pharma Buffer Market Size by Type
  11. 1.4.1 Global Bio Pharma Buffer Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Bio Pharma Buffer Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Bio Pharma Buffer Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Bio Pharma Buffer Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Bio Pharma Buffer Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Bio Pharma Buffer Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Bio Pharma Buffer Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Bio Pharma Buffer Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Bio Pharma Buffer Industry Trends
  2. 2.2 Bio Pharma Buffer Industry Drivers
  3. 2.3 Bio Pharma Buffer Industry Opportunities and Challenges
  4. 2.4 Bio Pharma Buffer Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Bio Pharma Buffer Revenue (2021-2026)
  2. 3.2 Global Top Players by Bio Pharma Buffer Sales (2021-2026)
  3. 3.3 Global Top Players by Bio Pharma Buffer Price (2021-2026)
  4. 3.4 Global Bio Pharma Buffer Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Bio Pharma Buffer Major Company Production Sites & Headquarters
  6. 3.6 Global Bio Pharma Buffer Company, Product Type & Application
  7. 3.7 Global Bio Pharma Buffer Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Bio Pharma Buffer Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Bio Pharma Buffer Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Bio Pharma Buffer Tier 1, Tier 2, and Tier 3
4 Bio Pharma Buffer Regional Status and Outlook
  1. 4.1 Global Bio Pharma Buffer Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Bio Pharma Buffer Historic Market Size by Region
  3. 4.2.1 Global Bio Pharma Buffer Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Bio Pharma Buffer Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Bio Pharma Buffer Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Bio Pharma Buffer Forecasted Market Size by Region
  7. 4.3.1 Global Bio Pharma Buffer Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Bio Pharma Buffer Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Bio Pharma Buffer Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Bio Pharma Buffer by Application
  1. 5.1 Bio Pharma Buffer Market by Application
  2. 5.1.1 Research Institution
  3. 5.1.2 Pharmaceutical Industry
  4. 5.1.3 Others
  5. 5.2 Global Bio Pharma Buffer Market Size by Application
  6. 5.2.1 Global Bio Pharma Buffer Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Bio Pharma Buffer Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Bio Pharma Buffer Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Bio Pharma Buffer Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Bio Pharma Buffer Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Bio Pharma Buffer Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Bio Pharma Buffer Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Bio Pharma Buffer Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Avantor
  2. 6.1.1 Avantor Company Information
  3. 6.1.2 Avantor Business Overview
  4. 6.1.3 Avantor Bio Pharma Buffer Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Avantor Bio Pharma Buffer Product Portfolio
  6. 6.1.5 Avantor Recent Developments
  7. 6.2 Alfa Aesar (Thermo Fisher)
  8. 6.2.1 Alfa Aesar (Thermo Fisher) Company Information
  9. 6.2.2 Alfa Aesar (Thermo Fisher) Business Overview
  10. 6.2.3 Alfa Aesar (Thermo Fisher) Bio Pharma Buffer Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Alfa Aesar (Thermo Fisher) Bio Pharma Buffer Product Portfolio
  12. 6.2.5 Alfa Aesar (Thermo Fisher) Recent Developments
  13. 6.3 Merck
  14. 6.3.1 Merck Company Information
  15. 6.3.2 Merck Business Overview
  16. 6.3.3 Merck Bio Pharma Buffer Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Merck Bio Pharma Buffer Product Portfolio
  18. 6.3.5 Merck Recent Developments
  19. 6.4 Lonza
  20. 6.4.1 Lonza Company Information
  21. 6.4.2 Lonza Business Overview
  22. 6.4.3 Lonza Bio Pharma Buffer Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Lonza Bio Pharma Buffer Product Portfolio
  24. 6.4.5 Lonza Recent Developments
  25. 6.5 Bio-Rad
  26. 6.5.1 Bio-Rad Company Information
  27. 6.5.2 Bio-Rad Business Overview
  28. 6.5.3 Bio-Rad Bio Pharma Buffer Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Bio-Rad Bio Pharma Buffer Product Portfolio
  30. 6.5.5 Bio-Rad Recent Developments
  31. 6.6 BD
  32. 6.6.1 BD Company Information
  33. 6.6.2 BD Business Overview
  34. 6.6.3 BD Bio Pharma Buffer Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 BD Bio Pharma Buffer Product Portfolio
  36. 6.6.5 BD Recent Developments
  37. 6.7 GE Healthcare
  38. 6.7.1 GE Healthcare Company Information
  39. 6.7.2 GE Healthcare Business Overview
  40. 6.7.3 GE Healthcare Bio Pharma Buffer Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 GE Healthcare Bio Pharma Buffer Product Portfolio
  42. 6.7.5 GE Healthcare Recent Developments
  43. 6.8 Promega Corporation
  44. 6.8.1 Promega Corporation Company Information
  45. 6.8.2 Promega Corporation Business Overview
  46. 6.8.3 Promega Corporation Bio Pharma Buffer Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Promega Corporation Bio Pharma Buffer Product Portfolio
  48. 6.8.5 Promega Corporation Recent Developments
  49. 6.9 Hamilton Company
  50. 6.9.1 Hamilton Company Company Information
  51. 6.9.2 Hamilton Company Business Overview
  52. 6.9.3 Hamilton Company Bio Pharma Buffer Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Hamilton Company Bio Pharma Buffer Product Portfolio
  54. 6.9.5 Hamilton Company Recent Developments
  55. 6.10 XZL BIO-TECHNOLOGY
  56. 6.10.1 XZL BIO-TECHNOLOGY Company Information
  57. 6.10.2 XZL BIO-TECHNOLOGY Business Overview
  58. 6.10.3 XZL BIO-TECHNOLOGY Bio Pharma Buffer Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 XZL BIO-TECHNOLOGY Bio Pharma Buffer Product Portfolio
  60. 6.10.5 XZL BIO-TECHNOLOGY Recent Developments
  61. 6.11 SRL
  62. 6.11.1 SRL Company Information
  63. 6.11.2 SRL Business Overview
  64. 6.11.3 SRL Bio Pharma Buffer Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 SRL Bio Pharma Buffer Product Portfolio
  66. 6.11.5 SRL Recent Developments
7 North America by Country
  1. 7.1 North America Bio Pharma Buffer Sales by Country
  2. 7.1.1 North America Bio Pharma Buffer Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Bio Pharma Buffer Sales by Country (2021-2026)
  4. 7.1.3 North America Bio Pharma Buffer Sales Forecast by Country (2027-2032)
  5. 7.2 North America Bio Pharma Buffer Market Size by Country
  6. 7.2.1 North America Bio Pharma Buffer Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Bio Pharma Buffer Market Size by Country (2021-2026)
  8. 7.2.3 North America Bio Pharma Buffer Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Bio Pharma Buffer Sales by Country
  2. 8.1.1 Europe Bio Pharma Buffer Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Bio Pharma Buffer Sales by Country (2021-2026)
  4. 8.1.3 Europe Bio Pharma Buffer Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Bio Pharma Buffer Market Size by Country
  6. 8.2.1 Europe Bio Pharma Buffer Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Bio Pharma Buffer Market Size by Country (2021-2026)
  8. 8.2.3 Europe Bio Pharma Buffer Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Bio Pharma Buffer Sales by Country
  2. 9.1.1 Asia-Pacific Bio Pharma Buffer Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Bio Pharma Buffer Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Bio Pharma Buffer Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Bio Pharma Buffer Market Size by Country
  6. 9.2.1 Asia-Pacific Bio Pharma Buffer Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Bio Pharma Buffer Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Bio Pharma Buffer Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Bio Pharma Buffer Sales by Country
  2. 10.1.1 South America Bio Pharma Buffer Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Bio Pharma Buffer Sales by Country (2021-2026)
  4. 10.1.3 South America Bio Pharma Buffer Sales Forecast by Country (2027-2032)
  5. 10.2 South America Bio Pharma Buffer Market Size by Country
  6. 10.2.1 South America Bio Pharma Buffer Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Bio Pharma Buffer Market Size by Country (2021-2026)
  8. 10.2.3 South America Bio Pharma Buffer Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Bio Pharma Buffer Sales by Country
  2. 11.1.1 Middle East and Africa Bio Pharma Buffer Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Bio Pharma Buffer Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Bio Pharma Buffer Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Bio Pharma Buffer Market Size by Country
  6. 11.2.1 Middle East and Africa Bio Pharma Buffer Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Bio Pharma Buffer Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Bio Pharma Buffer Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Bio Pharma Buffer Value Chain Analysis
  2. 12.1.1 Bio Pharma Buffer Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Bio Pharma Buffer Production Mode & Process
  7. 12.2 Bio Pharma Buffer Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Bio Pharma Buffer Distributors
  10. 12.2.3 Bio Pharma Buffer Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst